2012 Core Therapeutic Module, HIV and AIDS

ACPE Number: 0204-0000-12-953-H02-P
Application-based: 1.0 Credit Hour
Release Date: 6/15/2012
Expiration Date: 6/15/2015

Let ASHP’s new online core therapeutic modules help you prepare for any Board of Pharmacy Specialties (BPS) examination. Get comprehensive, practical guidance for patients with HIV and AIDS, as well as practice exam questions and references to helpful study resources.  This activity is available June 15, 2012 through June 15, 2015.

Featured topics in this online CE course include

• How to interpret diagnostic and laboratory tests, including viral loads and CD4 counts.
• Identifying patients at risk for opportunistic infections.
• Managing and prevent opportunistic infections.
• Explaining protocol for preventing vertical transmission of HIV.
• Explaining protocol for preventing HIV transmission via occupational exposure.
• Identifying drug-related problems, including drug interactions.
• Determining the most appropriate therapy and monitoring based on patient-specific information and the most current guidelines.

Led by therapeutic experts, each of the 14 modules (ranging from 1 to 2 hours in length) can be completed consecutively or individually in any order.  The online format offers the convenience of studying at your own pace. 

Included with this online course are complementary study resources including a practice exam and access to a virtual study group for a truly interactive experience.

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEUs) of continuing pharmacy education credit (ACPE activity #204-000-12-953-H02P).

Methods and Format

This activity is one of 14 modules in this series and can be completed consecutively or individually in any order. This online activity consists of audio and slides for one presentation, an attestation statement, and activity evaluation. Participants must view the entire presentation, complete the attestation statement and course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 1 hour.

Target Audience

This activity is intended for pharmacy practitioners who are seeking to update their knowledge and skills commensurate with a board certification examination.

Activity Content

The purpose of this activity is to help participants prepare for a Board of Pharmacy Specialty (BPS) examination by providing a review of pertinent topics, practice of required skills and references to helpful study resources. Faculty will discuss therapeutic management of issues and provide resources on the disease state. The activity will assist the participant identify areas needed for in-depth review.

Learning Objectives

After participating in this application-based educational activity, participants should be able to

• Interpret diagnostic and laboratory tests, including viral loads and CD4 counts.
• Identify patients at risk for opportunistic infections.
• Manage and prevent opportunistic infections.
• Explain protocols for preventing vertical transmission of HIV.
• Explain protocols for preventing HIV transmission via occupational exposure.
• Identify drug-related problems, including drug interactions.
• Determine the most appropriate therapy and monitoring based on patient-specific information and the most current guidelines.

Faculty

Douglas Slain, Pharm.D., BCPS
Associate Professor and Anti-infectious Diseases Clinical Specialist
West Virginia University
Morgantown, West Virginia

Dr. Douglas Slain, Pharm.D., BCPS, is Associate Professor and Anti-infectious Clinical Specialist at West Virginia University (WVU). He received his Bachelor of Science and Doctor of Pharmacy degree from Duquesne University in Pittsburgh, Pennsylvania. He completed a residency and fellowship in infectious diseases pharmacotherapy at the WVU’s Medical College of Virginia. Dr. Slain’s clinical practice sites at WVU include the infectious diseases consult service and the outpatient infectious diseases clinic. Dr. Slain has the distinction of being a Board Certified Pharmacotherapy Specialist (BCPS) with added qualifications in infectious diseases. The Society of Infectious Diseases Pharmacists also selected Dr. Slain as "Clinician of the Year" in 2007.

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.

The faculty and planners report the following relationships:

Douglas Slain, Pharm.D., BCPS
Dr. Slain declares that he has no relationships pertinent to this activity.

Christopher Betz, Pharm.D., BCPS
Dr. Betz declares that he has no relationships pertinent to this activity.

Sandra Oh Clarke, B.S.Pharm.
Ms. Oh Clarke declares that she has no relationships pertinent to this activity.

Susan R. Dombrowski, M.S., B.S.Pharm.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.

ASHP staff has no relevant financial relationships to disclose.